SCHEMBL16622854

SCHEMBL16622854

Cc1cc(C(=O)NC2CCCCC2)cc(C(=O)NC2CCCCC2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.71
RAB9A P51151 9/20 0.71
SMN1; SMN2 Q16637 4/20 0.70
HPGD P15428 3/20 0.70
CYP1A2 P05177 2/20 0.70
CYP2C19 P33261 2/20 0.70
TAS1R3 Q7RTX0 3/20 0.68
TAS1R1 Q7RTX1 3/20 0.68
TAS1R2 Q8TE23 3/20 0.68
KMT2A Q03164 3/20 0.64
MEN1 O00255 2/20 0.64
POLB P06746 1/20 0.54
KDM4E B2RXH2 1/20 0.54
GFER P55789 1/20 0.54
HSD17B10 Q99714 1/20 0.54
USP2 O75604 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
TP53 P04637 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16622857 1.00 NPC1 (0.71) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL16622859 1.00 NPC1 (0.71) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL16622850 0.98 RAB9A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL2911740 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL2915946 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL9978790 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL2908851 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL435720 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL9979280 0.91 KMT2A (0.69) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL16143123 0.89 NPC1 (0.62) NPC1RAB9ASMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9882136-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2018-01-30 US disclosed
EP-2858458-B1 ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2017-05-31 EP disclosed
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-10-08 US disclosed
EP-2858458-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2015-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE CDH1, STRA6, SLC39A7 NPC1 1060/4885RAB9A 732/4885SMN1; SMN2 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.